[Staphylococcus aureus producing Panton-Valentine leukocidin : notions in clinical practice].

Staphylococcal skin infections, especially recurrent abscesses, or those that do not respond to conventional treatment (drainage or antibiotics), are frequently associated with the Panton-Valentine leucocidin (PVL) toxin which may be diagnosed by PCR in the laboratory with a result within 24 hours. Treatment changes according to the clinical presentation and the resistance of Staphylococcus.The presence of these PVL-producing strains is increasingly frequent in clinical practice, partially because of the current migratory flow.

[Fitness to drive: specific supports in 2017].

In this article we discuss the clinical aspects of the examination of fitness to drive. The medical history and clinical examination are an essential first step in this assessment. This should be done in a systematic way and enable to highlight the potential « red flags », in other words medical conditions and the use of drugs increasing the risk of accidents.

[Fitness to drive : general aspects in 2017].

General practitioners, as well as many specialized physicians, are frequently confronted with the issue of fitness to drive for their patients. This is for periodically examinations imposed by the cantonal authority but also during their usual consultations. Any physician is supposed to identify situations where his (her) patient is unfit to drive and has an obligation of information.

[2016 literature findings in internal general medicine].

Treatment with diclofenac appears to be more effective compared to other NSAIDs in the treatment of osteoarthritis of the large joints. Opioids do not diminish significantly the pain in chronic lower back pain. Degenerative tears of the meniscus, without signs of osteoarthritis, should be treated conservatively.

[2015 literature findings in general internal medicine].

Benzodiazepines are associated with the risk of developing Alzheimer's disease. Systematic dosage and vitamin D substitution have no place in times of immediate post-menopause. Topical placebos challenge analgesics in the treatment of knee osteoarthritis.